𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P8 T cell responses in cancer patients after vaccination with a cryptic hTERT peptide (Vx-001)

✍ Scribed by E.-K. Vetsika; D. Aggouraki; G. Konsolakis; E. Bolonaki; D. Mavroudis; K. Kosmatopoulos; V. Georgoulias


Book ID
118626168
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
50 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Vaccination with a CDR2 BV6S2/6S5 peptid
✍ Elizabeth E. Morgan; Christopher J. Nardo; Jocelyn P. Diveley; Joel Kunin; Richa πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 87 KB

## Abstract Earlier studies from several groups including ours have documented that patients with multiple sclerosis (MS) have over‐expression of activated T‐cells from specific TCR VΞ² families, including BV6S2/S5 (Kotzin et al. [1991] Proc. Natl. Acad. Sci. USA 88:9161–9165; Gold et al. [1997] J.

p21-ras-peptide-specific T-cell response
✍ Beate Fossum; Tobias Gedde-Dahl III; Jarle Breivik; Jon Amund Eriksen; Anne Spur πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 979 KB

Peptides derived from mutated ras are immunogenic in mice and humans, and represent a group of specific tumor antigens that are potential targets for immunotherapy. T-cell responses against mutant p2I ras can be initiated in vitro by repeated stimulation of peripheral-blood mononuclear cells with mu